Particularities of Chronic Urticaria in Latin American Countries: Epidemiology, Pathogenesis and Treatment

ABSTRACT: Purpose of Review Chronic Urticaria is a multifactorial disease. Despite international guideline recommendations each region has particular characteristics with unique needs. The aim of this review is to present the particularities of urticaria in Latin America (LATAM) and evaluate the cli...

Full description

Autores:
Sánchez Caraballo, Jorge Mario
Larco, Jose Ignacio
Ensina, Luis
Álvarez, Leidy
Cherrez Ojeda, Iván
Tipo de recurso:
Article of investigation
Fecha de publicación:
2025
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/45259
Acceso en línea:
https://hdl.handle.net/10495/45259
Palabra clave:
Angioedema
Antagonistas de los Receptores Histamínicos
Histamine Antagonists
Urticaria Crónica
Chronic Urticaria
Omalizumab
América Latina
Latin America
https://id.nlm.nih.gov/mesh/D000799
https://id.nlm.nih.gov/mesh/D006633
https://id.nlm.nih.gov/mesh/D000080223
https://id.nlm.nih.gov/mesh/D000069444
https://id.nlm.nih.gov/mesh/D007843
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: Purpose of Review Chronic Urticaria is a multifactorial disease. Despite international guideline recommendations each region has particular characteristics with unique needs. The aim of this review is to present the particularities of urticaria in Latin America (LATAM) and evaluate the clinical and investigation costs of CSU in LATAM and other regions. Recent Findings In the last 10 years there has been a signifcant increase in research on CSU in LATAM. At the molecular level, the presence of specifc IgE against environmental allergens and eosinophils seems to be more frequent among CSU in LATAM than in other regions, suggesting a greater presence of type 2 infammation, perhaps secondary to the characteristics of the environment in some areas of LATAM. At a clinical level, there are common points and diferences with respect to what has been published in other regions, especially in terms of management secondary to economic access barriers. Summary It is important to understand the causes of these particularities to modify those that result in a high cost for the patient and society.